CoEHAR at the CORESTA Congress 2024 in Edinburgh
The CoEHAR researcher Dr. Lia Emma will attend the 2024 edition of the CORESTA Congress which will take place in Edinburgh, Scotland - UK, from 13-17 October
Groundbreaking Global Initiative to Investigate Oral Health Impacts of Combustion-Free Nicotine Delivery Alternatives: the SMILE Study
The study has been designed with the help of experts from Germany, UK, Italy, Poland, Moldova, and Indonesia. SMILE study is being conducted in four dental clinics across four different countries (Italy, Poland, Moldova, and Indonesia). Volunteer enrollment was completed in August 2023 and results will be expected to be available in 2025.
MAGNIFICAT project: dual user and harm reduction potential
On 19th January, in Hotel Palace Catania, there was a Kick-Off meeting held by CoEHAR, its Partners: ABF GmbH from Germany, PRATIA MTZ from Poland and supporting Parties such as…
CoEHAR: NO HEALTH RESPIRATORY EFFECTS REPORTED WITH ECIG SUBSTITUTION FOR SMOKING
In their work “Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review”, researchers analyzed 16 studies from 20 publications: most of the studies showed no difference in respiratory parameters. This indicates that electronic nicotine delivery systems substitution for smoking likely does not result in additional harm to respiratory health.
REPLICA STUDY: CoEHAR research shows minimal to zero cancerogenic effects of e-cigarettes
Replica researchers performed a standard toxicology battery of three assays used for product assessment and regulatory applications.
DiaSmokeFree Working Group Challenges American Diabetes Association Guidelines on E-Cigarette Use
The DiaSmokeFree Working Group send a letter to the American Diabetes Association (ADA) expressing concern and seeking correction of a couple of statements in the ADA guidelines regarding the use…
SIRC: Replica results at the 24th National Congress
Professor Li Volti talked about the Replica project results with a presentation titled "The impact of cigarette smoke and reduced risk products aerosol on endothelial function: the REPLICA project"
Atherosclerosis and smoking: Polosa at the SISA national conference
The conference will bring together leading experts in the field to discuss the latest research on dyslipidemias and their management. Topics to be covered include the latest guidelines from the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), as well as innovative topics such as environmental risk factors, including smoking, and their role in the progression of atherosclerosis.
6th Scientific Summit on THR – Athens
Prof. Giovanni Li Volti, director of CoEHAR e dr. Renèe O'Leary will be in conference as a speakers with two interesting abstract on Harm Reduction and CoEHAR research.
Doctors’ Survey: Italy results
86% of physicians believe that combustion is more harmful than nicotine. 64%-77% of physicians believe that nicotine directly causes various smoking-related conditions, with 19% to 32% believing strongly.
